Xi Ding
Dongtai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Systematic profiling of Taxol resistance and sensitivity to tubulin missence mutations at molecular and cellular levels.
Journal: Chemical biology & drug design
Published: January 19, 2024
Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
Journal: Molecular medicine reports
Published: January 25, 2021
Systematic molecular profiling of inhibitor response to the clinical missense mutations of ErbB family kinases in human gastric cancer.
Journal: Journal of molecular graphics & modelling
Published: November 04, 2019
Systematic Profiling and Evaluation of Structure-based Kinase-Inhibitor Interactome in Cervical Cancer by Integrating In Silico Analyses and In Vitro Assays at Molecular and Cellular Levels.
Journal: Computational biology and chemistry
Published: February 11, 2019
Molecular design of Stat3-derived peptide selectivity between BET proteins Brd2 and Brd4 in ovarian cancer.
Journal: Journal of molecular recognition : JMR
Published: June 15, 2017
Staurosporine scaffold-based rational discovery of the wild-type sparing reversible inhibitors of EGFR T790M gatekeeper mutant in lung cancer with analog-sensitive kinase technology.
Journal: Journal of molecular recognition : JMR
Published: August 20, 2016
Systematic profiling of chemotherapeutic drug response to EGFR gatekeeper mutation in non-small cell lung cancer.
Journal: Computational biology and chemistry
Published: March 23, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026